Abu Dhabi, United Arab Emirates; The 3rd annual Abu Dhabi ID Week kicks off in Abu Dhabi today in the presence of H.E Shaikh Abdullah Al Hamed Chairman of the Department of Health. The event brought together international and regional health leaders, and over 350 health care practitioners to discuss new anti-infectives, diagnostics, global health, and public-private partnerships with a special focus on promoting patient care and safety. 

In his opening remarks, H.E. Matar Al Nuaimi, Director General of the Abu Dhabi Public Health Center said: “Throughout the history, infectious diseases have claimed millions of human lives and continue to cause mortality and morbidity among many people in almost every corner of the world given that pathogens are evolving and increasing their resistance to different types of medication. That’s why we should join our efforts to control and eliminate infectious diseases.”  

Al Nuaimi added: “Here in Abu Dhabi we are lucky to have leaders who set an inspiring example for others to follow in the humanitarian filed. His Highness Sheikh Mohamed bin Zayed Al Nhayan, the Crown prince of Abu Dhabi Emirate and the Deputy Commander of the UAE Armed forces, together with Bill Gates the co-founder of Microsoft and co-chairman of the Bill and Melinda Gates Foundation supported the mission to eradicate polio since 2011 until now. Since then millions of children received vaccination against polio and polio eradication has never been so close to the finish line. The UAE leadership also continues to provide its full support to building and developing capabilities that are able to investigate and respond efficiently to infectious diseases.”


The event will feature interactive case-studies, platform presentations, educational workshops, networking sessions, to provide a comprehensive review of current issues and recent advances in selected ID topics, including AMR, Antimicrobial stewardship programs, Vaccination, outbreaks, Infection Control and other topics.

Abu Dhabi ID Week is organised by Maarefah Management, and is sponsored by Sanofi Pasteur, GSK and Medicines Malaria Venture.

-Ends-

About Maarefah Management: 

Maarefah Management is a world-class event, training and association management company that works closely with government institutions, industry bodies, and professional associations to help individual’s career development in order to grow and sustain successful businesses. Through four main divisions, Maarefah offers comprehensive professional services ranging from events management, leadership development training, market research and association administration across a number of industries. The company’s conferences and specialized training courses are developed by well experienced technical committees who create up-to-date scientific and technical programs tackling current and critical industry issues.

Visit: http://www.maarefah-management.com 

© Press Release 2019

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.